Alterity Therapeutics (ATHE) Change in Receivables (2009 - 2020)

Alterity Therapeutics' Change in Receivables history runs 11 years deep, the most recent figure standing at $898621.0 for Q2 2020.

• On a quarterly basis, Change in Receivables rose 176.49% year-over-year to $898621.0 in Q2 2020; TTM through Jun 2020 was -$542814.8, a 15.57% increase from a year earlier, with the FY2025 full-year figure at $66648.6, down 97.81% from the prior year.
• Change in Receivables advanced to $898621.0 in Q2 2020 per ATHE's latest filing, from -$2.0 million in the prior quarter.
• Across five years, Change in Receivables topped out at $1.7 million in Q4 2018 and bottomed at -$2.2 million in Q4 2016.
• The 5-year median for Change in Receivables is -$884.5 (2018), against an average of -$150911.9.
• Across the five-year window, Change in Receivables jumped 243.82% in 2018 and sank 132715.6% in 2019, its largest moves.
• Year by year, Change in Receivables stood at -$2.2 million in 2016, then soared by 44.88% to -$1.2 million in 2017, then soared by 243.82% to $1.7 million in 2018, then tumbled by 215.25% to -$2.0 million in 2019, then soared by 144.59% to $898621.0 in 2020.
• Per Business Quant, the three latest ATHE Change in Receivables figures stand at $898621.0 (Q2 2020), -$2.0 million (Q4 2019), and -$1.2 million (Q2 2019).